• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生命早期营养因素与自身免疫性糖尿病发生发展中的黏膜免疫

Early-Life Nutritional Factors and Mucosal Immunity in the Development of Autoimmune Diabetes.

作者信息

Xiao Ling, Van't Land Belinda, van de Worp Wouter R P H, Stahl Bernd, Folkerts Gert, Garssen Johan

机构信息

Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

Nutricia Research, Utrecht, Netherlands.

出版信息

Front Immunol. 2017 Sep 28;8:1219. doi: 10.3389/fimmu.2017.01219. eCollection 2017.

DOI:10.3389/fimmu.2017.01219
PMID:29033938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5626949/
Abstract

Type 1 diabetes (T1D) is an immune-mediated disease with a strong genetic basis but might be influenced by non-genetic factors such as microbiome development that "programs" the immune system during early life as well. Factors influencing pathogenesis, including a leaky intestinal mucosal barrier, an aberrant gut microbiota composition, and altered immune responsiveness, offer potential targets for prevention and/or treatment of T1D through nutritional or pharmacologic means. In this review, nutritional approaches during early life in order to protect against T1D development have been discussed. The critical role of tolerogenic dendritic cells in central and peripheral tolerance has been emphasized. In addition, since the gut microbiota affects the development of T1D through short-chain fatty acid (SCFA)-dependent mechanisms, we hypothesize that nutritional intervention boosting SCFA production may be used as a novel prevention strategy. Current retrospective evidence has suggested that exclusive and prolonged breastfeeding might play a protective role against the development of T1D. The beneficial properties of human milk are possibly attributed to its bioactive components such as unique immune-modulatory components human milk oligosaccharides and metabolites derived thereof, including SCFAs. These components might play a key role in healthy immune development and creating a fit and resilient immune system in early and later life.

摘要

1型糖尿病(T1D)是一种具有强大遗传基础的免疫介导性疾病,但可能受非遗传因素影响,如微生物群发育,其在生命早期也会对免疫系统进行“编程”。影响发病机制的因素,包括肠道黏膜屏障渗漏、肠道微生物群组成异常和免疫反应性改变,为通过营养或药物手段预防和/或治疗T1D提供了潜在靶点。在本综述中,讨论了生命早期预防T1D发生的营养方法。强调了耐受性树突状细胞在中枢和外周耐受中的关键作用。此外,由于肠道微生物群通过短链脂肪酸(SCFA)依赖性机制影响T1D的发展,我们假设促进SCFA产生的营养干预可能用作一种新的预防策略。目前的回顾性证据表明,纯母乳喂养和延长母乳喂养时间可能对T1D的发生起到保护作用。母乳的有益特性可能归因于其生物活性成分,如独特的免疫调节成分人乳寡糖及其衍生的代谢产物,包括SCFA。这些成分可能在健康的免疫发育以及在生命早期和后期建立健康且有弹性的免疫系统中发挥关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/5626949/d47b4c687458/fimmu-08-01219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/5626949/9e8a6b624b4f/fimmu-08-01219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/5626949/bb9b0e5d0e69/fimmu-08-01219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/5626949/79fcfab15d49/fimmu-08-01219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/5626949/d47b4c687458/fimmu-08-01219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/5626949/9e8a6b624b4f/fimmu-08-01219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/5626949/bb9b0e5d0e69/fimmu-08-01219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/5626949/79fcfab15d49/fimmu-08-01219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/5626949/d47b4c687458/fimmu-08-01219-g004.jpg

相似文献

1
Early-Life Nutritional Factors and Mucosal Immunity in the Development of Autoimmune Diabetes.生命早期营养因素与自身免疫性糖尿病发生发展中的黏膜免疫
Front Immunol. 2017 Sep 28;8:1219. doi: 10.3389/fimmu.2017.01219. eCollection 2017.
2
Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice.人乳寡糖可预防 NOD 小鼠自身免疫性糖尿病的发生。
Sci Rep. 2018 Mar 1;8(1):3829. doi: 10.1038/s41598-018-22052-y.
3
On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota.关于胰岛素依赖型糖尿病的发病机制:微生物群的作用。
Immunol Res. 2017 Feb;65(1):242-256. doi: 10.1007/s12026-016-8832-8.
4
Can the FUT2 Phenotype Associated With Gut Microbiota Increase the Children Susceptibility for Type 1 Diabetes? A Mini Review.与肠道微生物群相关的FUT2表型会增加儿童患1型糖尿病的易感性吗?一篇综述。
Front Nutr. 2020 Dec 23;7:606171. doi: 10.3389/fnut.2020.606171. eCollection 2020.
5
Butyrate: A Link between Early Life Nutrition and Gut Microbiome in the Development of Food Allergy.丁酸盐:食物过敏发展过程中早期营养与肠道微生物群之间的联系。
Life (Basel). 2021 Apr 23;11(5):384. doi: 10.3390/life11050384.
6
Early nutrition and immunity - progress and perspectives.早期营养与免疫——进展与展望
Br J Nutr. 2006 Oct;96(4):774-90.
7
Immune recognition and response to the intestinal microbiome in type 1 diabetes.1 型糖尿病中对肠道微生物组的免疫识别和反应。
J Autoimmun. 2016 Jul;71:10-8. doi: 10.1016/j.jaut.2016.02.004. Epub 2016 Feb 20.
8
FFAR from the Gut Microbiome Crowd: SCFA Receptors in T1D Pathology.来自肠道微生物群领域的游离脂肪酸受体:1型糖尿病病理学中的短链脂肪酸受体
Metabolites. 2021 May 11;11(5):302. doi: 10.3390/metabo11050302.
9
Diversity of Human Milk Oligosaccharides and Effects on Early Life Immune Development.人乳寡糖的多样性及其对早期生命免疫发育的影响。
Front Pediatr. 2018 Sep 10;6:239. doi: 10.3389/fped.2018.00239. eCollection 2018.
10
Homeostasis of the gut barrier and potential biomarkers.肠道屏障的稳态及潜在生物标志物。
Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G171-G193. doi: 10.1152/ajpgi.00048.2015. Epub 2016 Dec 1.

引用本文的文献

1
Interactions of human milk oligosaccharides with the immune system.人乳寡糖与免疫系统的相互作用。
Front Immunol. 2025 Jan 14;15:1523829. doi: 10.3389/fimmu.2024.1523829. eCollection 2024.
2
Targeted nutritional intervention attenuates experimental lung cancer cachexia.靶向营养干预可减轻实验性肺癌恶病质。
J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):1664-1676. doi: 10.1002/jcsm.13520. Epub 2024 Jul 4.
3
Study of the gut microbiome in Egyptian patients with type 1 diabetes mellitus.埃及1型糖尿病患者肠道微生物群的研究。

本文引用的文献

1
Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2).中性内肽酶是血管紧张素 -(1 - 7)通过其蛋白水解活性生成血管紧张素 -(1 - 2)来增强胰岛素分泌能力所必需的。
Diabetes. 2017 Aug;66(8):2201-2212. doi: 10.2337/db16-1318. Epub 2017 May 30.
2
Infant Feeding and Risk of Type 1 Diabetes in Two Large Scandinavian Birth Cohorts.两个大型斯堪的纳维亚出生队列中的婴儿喂养与1型糖尿病风险
Diabetes Care. 2017 Jul;40(7):920-927. doi: 10.2337/dc17-0016. Epub 2017 May 9.
3
Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity.
Prz Gastroenterol. 2023;18(2):190-197. doi: 10.5114/pg.2023.126055. Epub 2023 Mar 22.
4
Immunomodulatory Effects of Microbiota-Derived Short-Chain Fatty Acids in Autoimmune Liver Diseases.肠道菌群衍生短链脂肪酸在自身免疫性肝病中的免疫调节作用。
J Immunol. 2023 Jun 1;210(11):1629-1639. doi: 10.4049/jimmunol.2300016.
5
An Expert Panel Statement on the Beneficial Effects of Human Milk Oligosaccharides (HMOs) in Early Life and Potential Utility of HMO-Supplemented Infant Formula in Cow's Milk Protein Allergy.关于人乳寡糖(HMOs)在生命早期的有益作用以及添加HMO的婴儿配方奶粉在牛奶蛋白过敏中的潜在效用的专家小组声明
J Asthma Allergy. 2021 Sep 24;14:1147-1164. doi: 10.2147/JAA.S323734. eCollection 2021.
6
Early-life fingolimod treatment improves intestinal homeostasis and pancreatic immune tolerance in non-obese diabetic mice.早期芬戈莫德治疗可改善非肥胖型糖尿病小鼠的肠道稳态和胰腺免疫耐受。
Acta Pharmacol Sin. 2021 Oct;42(10):1620-1629. doi: 10.1038/s41401-020-00590-4. Epub 2021 Jan 20.
7
Early Nutrition and Risk of Type 1 Diabetes: The Role of Gut Microbiota.早期营养与1型糖尿病风险:肠道微生物群的作用
Front Nutr. 2020 Dec 23;7:612377. doi: 10.3389/fnut.2020.612377. eCollection 2020.
8
Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models.癌症恶病质的营养干预:来自实验模型的证据与观点
Front Nutr. 2020 Dec 22;7:601329. doi: 10.3389/fnut.2020.601329. eCollection 2020.
9
Prenatal and postnatal determinants in shaping offspring's microbiome in the first 1000 days: study protocol and preliminary results at one month of life.在生命的头 1000 天中塑造后代微生物组的产前和产后决定因素:研究方案和一个月时的初步结果。
Ital J Pediatr. 2020 Apr 15;46(1):45. doi: 10.1186/s13052-020-0794-8.
10
Association between Bioactive Molecules in Breast Milk and Type 1 Diabetes Mellitus.母乳中的生物活性分子与1型糖尿病之间的关联
Sultan Qaboos Univ Med J. 2020 Feb;20(1):e5-e12. doi: 10.18295/squmj.2020.20.01.002. Epub 2020 Mar 9.
婴儿期脂肪酸状况与 1 型糖尿病相关自身免疫风险有关。
Diabetologia. 2017 Jul;60(7):1223-1233. doi: 10.1007/s00125-017-4280-9. Epub 2017 May 4.
4
Dietary short-chain fatty acids protect against type 1 diabetes.膳食短链脂肪酸可预防1型糖尿病。
Nat Immunol. 2017 Apr 18;18(5):484-486. doi: 10.1038/ni.3730.
5
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.2002 - 2012年间青少年1型和2型糖尿病的发病率趋势
N Engl J Med. 2017 Apr 13;376(15):1419-1429. doi: 10.1056/NEJMoa1610187.
6
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes.肠道微生物代谢产物可限制自身免疫性 T 细胞的频率,并预防 1 型糖尿病。
Nat Immunol. 2017 May;18(5):552-562. doi: 10.1038/ni.3713. Epub 2017 Mar 27.
7
Does infant feeding modulate the manifestation of celiac disease and type 1 diabetes?婴儿喂养方式是否会调节乳糜泻和1型糖尿病的表现?
Curr Opin Clin Nutr Metab Care. 2017 May;20(3):222-226. doi: 10.1097/MCO.0000000000000367.
8
Diet-Derived Short Chain Fatty Acids Stimulate Intestinal Epithelial Cells To Induce Mucosal Tolerogenic Dendritic Cells.饮食来源的短链脂肪酸刺激肠上皮细胞诱导黏膜耐受性树突状细胞。
J Immunol. 2017 Mar 1;198(5):2172-2181. doi: 10.4049/jimmunol.1600165. Epub 2017 Jan 18.
9
Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune Disorders.超越系统医学拥抱复杂性:慢性免疫疾病的新方法
Front Immunol. 2016 Dec 12;7:587. doi: 10.3389/fimmu.2016.00587. eCollection 2016.
10
Tolerogenic dendritic cells.耐受性树突状细胞
Semin Immunopathol. 2017 Feb;39(2):113-120. doi: 10.1007/s00281-016-0587-8. Epub 2016 Sep 19.